×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QURE – uniqure n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QURE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:05 am
qure
uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
Low
Report
uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
11/6
02:10 pm
qure
uniQure (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
11/6
01:10 pm
qure
uniQure (NASDAQ: QURE) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $10.00 to $9.00. They now have a "neutral" rating on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $10.00 to $9.00. They now have a "neutral" rating on the stock.
11/6
12:23 pm
qure
uniQure (NASDAQ: QURE) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $14.00. They now have an "outperform" rating on the stock.
Low
Report
uniQure (NASDAQ: QURE) had its price target lowered by analysts at Royal Bank of Canada from $16.00 to $14.00. They now have an "outperform" rating on the stock.
11/6
10:18 am
qure
uniQure (NASDAQ: QURE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
High
Report
uniQure (NASDAQ: QURE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $28.00 price target on the stock.
11/5
10:05 am
qure
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
Medium
Report
UniQure (QURE) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]
11/5
07:05 am
qure
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
High
Report
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
10/17
02:01 am
qure
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
uniQure (NASDAQ: QURE) was upgraded by analysts at StockNews.com to a "sell" rating.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
09:01 am
qure
Form 8-K uniQure N.V. For: Nov 21
Low
Report
Form 8-K uniQure N.V. For: Nov 21
11/14
04:56 pm
qure
Form SCHEDULE 13G/A uniQure N.V. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A uniQure N.V. Filed by: Nantahala Capital Management, LLC
11/14
12:02 pm
qure
Form SC 13G/A uniQure N.V. Filed by: Vestal Point Capital, LP
Low
Report
Form SC 13G/A uniQure N.V. Filed by: Vestal Point Capital, LP
11/13
04:06 pm
qure
Form SC 13G/A uniQure N.V. Filed by: BRISTOL MYERS SQUIBB CO
Low
Report
Form SC 13G/A uniQure N.V. Filed by: BRISTOL MYERS SQUIBB CO
11/5
09:09 am
qure
Form 10-Q uniQure N.V. For: Sep 30
High
Report
Form 10-Q uniQure N.V. For: Sep 30
11/5
08:03 am
qure
Form 8-K uniQure N.V. For: Nov 05
High
Report
Form 8-K uniQure N.V. For: Nov 05
10/25
09:49 pm
qure
Form SC 13G/A uniQure N.V. Filed by: Boxer Capital Management, LLC
Low
Report
Form SC 13G/A uniQure N.V. Filed by: Boxer Capital Management, LLC
10/18
12:07 pm
qure
Form SC 13G/A uniQure N.V. Filed by: STATE STREET CORP
Low
Report
Form SC 13G/A uniQure N.V. Filed by: STATE STREET CORP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.
11.2%
6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%
10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%
5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%
6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%
3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%
1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%
5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%
5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%
4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%
6/16 UniQure NV weighs options including sale -Bloomberg [Reuters] 11.2%
10/25 Form 4 uniQure N.V. For: Oct 23 Filed by: Kapusta Matthew C 7.0%
5/10 uniQure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B 7.0%
6/11 Uniqure NV (NASDAQ: QURE) had its "buy" rating re-affirmed by analysts at Janney Montgomery Scott. 5.9%
3/24 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.2%
1/31 Form 4 uniQure N.V. For: Jan 31 Filed by: van Deventer Sander 5.1%
5/16 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 4.3%
5/21 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 3.9%
4/24 Form 4 uniQure N.V. For: Apr 22 Filed by: Kapusta Matthew C 3.8%
TOP News Decliners
9/4
uniQure Announces Proposed Public Offering
-14.9%
5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%
2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%
7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%
9/5 uniQure Announces Pricing of its Public Offering -6.1%
3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%
1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%
3/2 Form 424B5 uniQure N.V. -5.6%
8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%
5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%
5/12 Uniqure NV (NASDAQ: QURE) was given a new $81.00 price target on by analysts at Cantor Fitzgerald. They now have a "buy" rating on the stock. -7.0%
2/25 Uniqure NV (NASDAQ: QURE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.6%
7/29 Q2/2019 6/30/2019 EPS -0.830 ZacksConsensus N/A ActVsEst N/A - N/A -6.2%
9/5 uniQure Announces Pricing of its Public Offering -6.1%
3/6 Form 3/A uniQure N.V. For: Aug 07 Filed by: KLEMT CHRISTIAN -5.8%
1/29 Form 4 uniQure N.V. For: Jan 27 Filed by: Gut Robert -5.8%
3/2 Form 424B5 uniQure N.V. -5.6%
8/23 Form 4 uniQure N.V. For: Aug 21 Filed by: Kapusta Matthew C -5.0%
5/1 Uniqure NV (NASDAQ: QURE) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $71.00 price target on the stock. -4.9%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: